Skip to main content
. 2020 Apr 15;5:100029. doi: 10.1016/j.ijchy.2020.100029
Highlights Class of Recommendation Level of Evidence
  • Currently, hypokalemia is absent in the majority of PA patients and, therefore, cannot be used as a screening test.

II B
  • Withdrawal of all antihypertensive medications is not recommended for measurement of the ARR.

III C
  • Patients should be worked-up for PA under proper conditions (i.e. normokalemia and switching to none interfering treatment).

II A
  • In patients with marked hypokalemia and/or drug-resistant hypertension MRAs can be administered during screening.

II B
  • The finding of high PAC and low renin while on drugs expected to rise renin and lower PAC, can allow the diagnosis of PA.

II B
  • The clinical use of ARR requires careful considerations to the actual values of PAC and renin, and to the factors that can influence these values.

II B